The workgroup approved 6 measures: (1) Annual cognitive health assessment for patients ≥ 65 years and for patients with neurologic illnesses at any age (2) Cognitive and functional assessment for patients with MCI or memory loss (3) MCI diagnosis disclosed and counseled on treatment options (4) Assessment and treatment of factors contributing to MCI (5) Avoidance of anticholinergic medications for patients with MCI (6) Education provided to care partners of patients with MCI.

Special Article: Quality Improvement In Neurology: MCI cognitive impairment quality measurement set